Clinical Trial Update: Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)

View source ↗

Summary

This update notes that the pre-approval access single-patient program for Teclistamab (JNJ-64007957) in multiple myeloma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Multiple Myeloma | Status: NO_LONGER_AVAILABLE